| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |